Preservation of Cardiac Xenografts in a Model of Infant Human Cardiac Transplantation
Xenotransplantation · 2025
DOI: 10.1111/xen.70009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Xenotransplantation, 2025. Verfasst von Chace B Mitchell und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Department of Surgery, Children's Hospital of Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Heart Transplantation, Transplantation, Heterologous, Heterografts, Organ Preservation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NHLBI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Introduction
There is no standard protocol for management of organ preservation for orthotopic, life‐sustaining cardiac xenotransplantation, particularly for hearts from pediatric sized donors. Standard techniques and solutions successful in human allotransplantation are not viable. We theorized that a solution commonly used in reparative cardiac surgery in human children would suffice by exploiting the advantages inherent to xenotransplantation, namely the ability to reduce organ ischemic times by co‐locating the donor and recipient.
Methods
Orthotopic cardiac xenotransplantation was performed from genetically engineered pigs to size matched baboons. A dose of modified Del Nido cardioplegia initiated donor heart arrest and was followed by a second dose mixed with recipient blood prior to implant. Hemodynamics and cardiac function were tracked with a combination of invasive and non‐invasive measures.
Results
Mean ischemic time and cardiopulmonary bypass times were 54.1 ± 14.6 and 84.1 ± 14 min respectively. The ejection fraction following chest closure was preserved at >50% for all animals. This finding persisted at 48hours. Mean inotropic score at 24 h post‐implant was 9.7 ± 3.
Conclusion
Del Nido cardioplegia solution when combined with short graft ischemic times demonstrates promising outcomes to avoid primary graft dysfunction for cardiac xenografts in a small animal model of life‐sustaining orthotopic cardiac xenotransplantation. Ex vivo perfusion systems may be unnecessary for successful clinical implementation of this evolving technology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiac Surgery, Department of Surgery, Children's Hospital of Los Angeles, Los Angeles, California, USA.
- Michale E. Keeling Center for Comparative Medicine, MD Anderson Cancer Center, Bastrop, Texas, USA.
- Department of Anesthesia, Children's Hospital of Los Angeles, Los Angeles, California, USA.
- Division of Cardiac Perfusion, Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
ORCID-Profile: Chace B Mitchell, Joe Simmons, Carolyn L Hodo
Förderung
- NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
Zitieren
APA
Mitchell, C. B., Simmons, J., Vo, C., Bakshi, K., Juliani, J., Fenske, J., Hodo, C. L., Cleveland, D. C., & Cleveland, J. D. (2025). Preservation of Cardiac Xenografts in a Model of Infant Human Cardiac Transplantation. Xenotransplantation. https://doi.org/10.1111/xen.70009
Vancouver
Mitchell CB, Simmons J, Vo C, Bakshi K, Juliani J, Fenske J, et al. Preservation of Cardiac Xenografts in a Model of Infant Human Cardiac Transplantation. Xenotransplantation. 2025. doi:10.1111/xen.70009
BibTeX
@article{Mitchell2025,
author = {Mitchell, Chace B and Simmons, Joe and Vo, Clementine and Bakshi, Kanwarpal and Juliani, Julie and Fenske, Julie and Hodo, Carolyn L and Cleveland, David C and Cleveland, John D},
title = {Preservation of Cardiac Xenografts in a Model of Infant Human Cardiac Transplantation},
journal = {Xenotransplantation},
year = {2025},
doi = {10.1111/xen.70009}
}
EUVIMED